- Home
- IHT vs ALLK Comparison
IHT vs ALLK Comparison
Compare IHT & ALLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IHT
- ALLK
- Stock Information
- Founded
- IHT 1971
- ALLK 2012
- Country
- IHT United States
- ALLK United States
- Employees
- IHT N/A
- ALLK N/A
- Industry
- IHT Investment Bankers/Brokers/Service
- ALLK Biotechnology: Pharmaceutical Preparations
- Sector
- IHT Finance
- ALLK Health Care
- Exchange
- IHT Nasdaq
- ALLK Nasdaq
- Market Cap
- IHT 22.2M
- ALLK 23.3M
- IPO Year
- IHT N/A
- ALLK 2018
- Fundamental
- Price
- IHT $2.64
- ALLK $0.26
- Analyst Decision
- IHT
- ALLK Hold
- Analyst Count
- IHT 0
- ALLK 3
- Target Price
- IHT N/A
- ALLK $2.00
- AVG Volume (30 Days)
- IHT 2.3K
- ALLK 1.1M
- Earning Date
- IHT 04-07-2025
- ALLK 05-08-2025
- Dividend Yield
- IHT 0.75%
- ALLK N/A
- EPS Growth
- IHT N/A
- ALLK N/A
- EPS
- IHT N/A
- ALLK N/A
- Revenue
- IHT $7,692,305.00
- ALLK N/A
- Revenue This Year
- IHT N/A
- ALLK N/A
- Revenue Next Year
- IHT N/A
- ALLK N/A
- P/E Ratio
- IHT N/A
- ALLK N/A
- Revenue Growth
- IHT 4.55
- ALLK N/A
- 52 Week Low
- IHT $1.25
- ALLK $0.23
- 52 Week High
- IHT $2.70
- ALLK $1.56
- Technical
- Relative Strength Index (RSI)
- IHT 49.09
- ALLK 32.71
- Support Level
- IHT $2.53
- ALLK $0.24
- Resistance Level
- IHT $2.69
- ALLK $0.29
- Average True Range (ATR)
- IHT 0.07
- ALLK 0.02
- MACD
- IHT -0.01
- ALLK 0.02
- Stochastic Oscillator
- IHT 33.63
- ALLK 22.29
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.